SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Tandem Diabetes Care Inc. – ‘10-K’ for 12/31/23 – ‘EX-97’

On:  Wednesday, 2/21/24, at 4:33pm ET   ·   For:  12/31/23   ·   Accession #:  1438133-24-28   ·   File #:  1-36189

Previous ‘10-K’:  ‘10-K’ on 2/22/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   18 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/21/24  Tandem Diabetes Care Inc.         10-K       12/31/23   95:10M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.04M 
 2: EX-4.2      EX-4.2 Description of Capital Stock                 HTML     34K 
 3: EX-10.25    EX-10.25 Employee Offer Letter                      HTML     39K 
 4: EX-21.1     EX-21.1 Subsidiaries of the Registrant              HTML     26K 
 5: EX-23.1     EX-23.1 Consent                                     HTML     27K 
10: EX-97       EX-97 Clawback Policy                               HTML     46K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     27K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     27K 
16: R1          Cover Page                                          HTML     92K 
17: R2          Audit Information                                   HTML     31K 
18: R3          Consolidated Balance Sheets                         HTML    129K 
19: R4          Consolidated Balance Sheets (Parenthetical)         HTML     36K 
20: R5          Consolidated Statements of Operations and           HTML    115K 
                Comprehensive Income (Loss)                                      
21: R6          Condensed Consolidated Statements of Stockholders?  HTML    101K 
                Equity                                                           
22: R7          Consolidated Statements of Cash Flows               HTML    135K 
23: R8          Organization and Basis of Presentation              HTML     33K 
24: R9          Summary of Significant Accounting Policies          HTML    122K 
25: R10         Short-Term Investments                              HTML     77K 
26: R11         Composition of Certain Financial Statement Items    HTML     70K 
27: R12         Fair Value Measurements                             HTML     70K 
28: R13         Leases                                              HTML     67K 
29: R14         Debt                                                HTML     60K 
30: R15         Stockholders' Equity                                HTML    140K 
31: R16         Employee Benefits                                   HTML     29K 
32: R17         Income Taxes                                        HTML    111K 
33: R18         Business Segment and Geographic Information         HTML     45K 
34: R19         Acquisitions                                        HTML     33K 
35: R20         Commitments and Contingencies                       HTML     33K 
36: R21         Fourth Quarter Financial Data (Unaudited)           HTML     40K 
37: R22         Subsequent Event                                    HTML     28K 
38: R23         Organization and Basis of Presentation (Policies)   HTML    125K 
39: R24         Summary of Significant Accounting Policies          HTML     97K 
                (Tables)                                                         
40: R25         Short-Term Investments (Tables)                     HTML     76K 
41: R26         Composition of Certain Financial Statement Items    HTML     78K 
                (Tables)                                                         
42: R27         Fair Value Measurements (Tables)                    HTML     65K 
43: R28         Leases (Tables)                                     HTML     60K 
44: R29         Debt (Tables)                                       HTML     44K 
45: R30         Stockholders' Equity (Tables)                       HTML    139K 
46: R31         Income Taxes (Tables)                               HTML    110K 
47: R32         Business Segment and Geographic Information         HTML     38K 
                (Tables)                                                         
48: R33         Fourth Quarter Financial Data (Unaudited) (Tables)  HTML     39K 
49: R34         Organization and Basis of Presentation (Details)    HTML     30K 
50: R35         Summary of Significant Accounting Policies -        HTML     67K 
                Additional Information (Details)                                 
51: R36         Summary of Significant Accounting Policies -        HTML     43K 
                Customers Accounted for 10% or More (Detail)                     
52: R37         Summary of Significant Accounting Policies -        HTML     42K 
                Reconciliation of Change in Estimated Warranty                   
                Liabilities (Details)                                            
53: R38         Summary of Significant Accounting Policies -        HTML     56K 
                Numerator and Denominator of the Basic and Diluted               
                Net Income (Loss) Per Share Computations (Details)               
54: R39         Summary of Significant Accounting Policies -        HTML     42K 
                Anti-Dilutive Securities (Details)                               
55: R40         Short-Term Investments - Estimated Fair Value of    HTML     52K 
                Short-Term Investments (Details)                                 
56: R41         Short-Term Investments - Contractual Maturities of  HTML     48K 
                Available - For- Sale Debt Securities (Details)                  
57: R42         Composition of Certain Financial Statement Items -  HTML     35K 
                Accounts Receivable (Details)                                    
58: R43         Composition of Certain Financial Statement Items -  HTML     34K 
                Reconciliation of Change in Estimated Allowance                  
                for Doubtful Accounts (Details)                                  
59: R44         Composition of Certain Financial Statement Items -  HTML     34K 
                Inventory (Details)                                              
60: R45         Composition of Certain Financial Statement Items -  HTML     43K 
                Summary of Property and Equipment (Detail)                       
61: R46         Composition of Certain Financial Statement Items -  HTML     36K 
                Additional Information (Detail)                                  
62: R47         Composition of Certain Financial Statement Items -  HTML     35K 
                Intangible Assets Subject to Amortization                        
                (Details)                                                        
63: R48         Fair Value Measurements - Financial Assets and      HTML     84K 
                Liabilities Measured at Fair Value on Recurring                  
                Basis (Details)                                                  
64: R49         Leases - Additional Information (Details)           HTML     97K 
65: R50         Leases - Lease Cost, Lease Term Discount Rate,      HTML     39K 
                Operating Leases (Details)                                       
66: R51         Leases - Future Minimum Payments Under              HTML     49K 
                Non-cancellable Operating Leases (Details)                       
67: R52         Leases - Lease Payments (Details)                   HTML     31K 
68: R53         Debt - Additional Information (Details)             HTML    127K 
69: R54         Debt - Components of Convertible Note (Details)     HTML     44K 
70: R55         Debt - Interest Expense Recognized (Details)        HTML     46K 
71: R56         Stockholders' Equity -Shares of Common Stock        HTML     51K 
                Reserved for Future Issuance (Details)                           
72: R57         Stockholders' Equity - Common Stock Warrants        HTML     39K 
                (Details)                                                        
73: R58         Stockholders' Equity - Additional Information       HTML    101K 
                (Details)                                                        
74: R59         Stockholders' Equity - Summary of Stock Option      HTML     81K 
                Activities for 2006 Plan and 2013 Plan (Detail)                  
75: R60         Stockholders' Equity - Restricted Stock Units       HTML     61K 
                (RSUs) (Details)                                                 
76: R61         Stockholders' Equity - Assumptions Used in          HTML     54K 
                Black-Scholes Option-Pricing Model (Details)                     
77: R62         Stockholders' Equity - Allocation of Stock-Based    HTML     43K 
                Compensation Expense (Details)                                   
78: R63         Employee Benefits - Additional Information          HTML     29K 
                (Details)                                                        
79: R64         Income Taxes - Income (Loss) Before Provision for   HTML     36K 
                Income Taxes (Details)                                           
80: R65         Income Taxes - Schedule of Components of Income     HTML     54K 
                Tax (Details)                                                    
81: R66         Income Taxes - Income Tax Expense (Details)         HTML     53K 
82: R67         Income Taxes - Additional Information (Details)     HTML     62K 
83: R68         Income Taxes - Schedule of Deferred Tax Assets and  HTML     57K 
                Liabilities (Details)                                            
84: R69         Income Taxes - Schedule of Unrecognized Tax         HTML     36K 
                Benefits (Detail)                                                
85: R70         Business Segment and Geographic Information -       HTML     38K 
                Additional Information (Details)                                 
86: R71         Business Segment and Geographic Information -       HTML     38K 
                Geographical Markets (Details)                                   
87: R72         Acquisitions (Details)                              HTML     54K 
88: R73         Commitments and Contingencies (Details)             HTML     31K 
89: R74         Fourth Quarter Financial Data (Unaudited) (Detail)  HTML     74K 
90: R9999       Uncategorized Items - tndm-20231231.htm             HTML     45K 
92: XML         IDEA XML File -- Filing Summary                      XML    166K 
95: XML         XBRL Instance -- tndm-20231231_htm                   XML   2.12M 
91: EXCEL       IDEA Workbook of Financial Report Info              XLSX    184K 
12: EX-101.CAL  XBRL Calculations -- tndm-20231231_cal               XML    255K 
13: EX-101.DEF  XBRL Definitions -- tndm-20231231_def                XML    631K 
14: EX-101.LAB  XBRL Labels -- tndm-20231231_lab                     XML   1.94M 
15: EX-101.PRE  XBRL Presentations -- tndm-20231231_pre              XML   1.15M 
11: EX-101.SCH  XBRL Schema -- tndm-20231231                         XSD    182K 
93: JSON        XBRL Instance as JSON Data -- MetaLinks              571±   871K 
94: ZIP         XBRL Zipped Folder -- 0001438133-24-000028-xbrl      Zip    918K 


‘EX-97’   —   EX-97 Clawback Policy


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  
Exhibit 97

TANDEM DIABETES CARE, INC.
CLAWBACK POLICY
1.GENERAL

The Compensation Committee (the “Compensation Committee”) of the Board of Directors (the “Board”) of Tandem Diabetes Care, Inc., a Delaware corporation (the “Company”) has determined that it is in the best interests of the Company and its stockholders to adopt this Clawback Policy (this “Policy”) providing for the Company’s recoupment of Recoverable Incentive Compensation that is received by Covered Officers of the Company under certain circumstances. Certain capitalized terms used in this Policy have the meanings given to such terms in Section 3 below. This Policy is designed to comply with, and shall be interpreted to be consistent with, Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder (“Rule 10D-1”) and Nasdaq Listing Rule 5608 (the “Listing Standards”).

2.EFFECTIVE DATE

This Policy shall apply to all Incentive Compensation that is received by a Covered Officer on or after October 2, 2023 (the “Effective Date”). Incentive Compensation is deemed “received” in the Company’s fiscal period in which the Financial Reporting Measure specified in the Incentive Compensation award is attained, even if the payment or grant of such Incentive Compensation occurs after the end of that period. For example, if a Financial Reporting Measure specified in an Incentive Compensation award is attained on June 30, 2024 and the associated Incentive Compensation is paid in March 2025, the Incentive Compensation is deemed received in the fiscal quarter ended June 30, 2024 rather than the fiscal quarter ended March 31, 2025. The clawback policy adopted by the Board on August 19, 2020 (the “Original Policy”) shall continue to apply to Incentive Compensation (as defined in the Original Policy) received by an Executive Officer or Non-Officer Employee (each, as defined in the Original Policy) from the date of the Original Policy until immediately prior to the Effective Date.

3.DEFINITIONS

For purposes of this Policy, the following terms shall have the meanings set forth below:

3.1Accounting Restatement means an accounting restatement that the Company is required to prepare due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.

3.2Accounting Restatement Date means the earlier to occur of (a) the date that the Board, a committee of the Board authorized to take such action, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement, or (b) the date that a court, regulator or other legally authorized body directs the Company to prepare an Accounting Restatement.

3.3Administrator means the Compensation Committee or, in the absence of such committee, the Board.

3.4Code means the U.S. Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.

3.5Compensation Committee means the Compensation Committee of the Board.

1

Exhibit 97
3.6Covered Officer means each current and former Executive Officer.

3.7Exchange means the Nasdaq Stock Market.

3.8Exchange Act means the Securities and Exchange Act of 1934, as amended.

3.9Executive Officer means the Company’s president, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or finance), any other officer who performs a policy-making function, or any other person who performs similar policy-making functions for the Company. Executive officers of the Company’s parent(s) or subsidiaries are deemed executive officers of the Company if they perform such policy-making functions for the Company. Policy-making function is not intended to include policy-making functions that are not significant. Identification of an executive officer for purposes of this Policy would include at a minimum executive officers identified pursuant to Item 401(b) of Regulation S-K promulgated under the Exchange Act.

3.10Financial Reporting Measures means measures that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures derived wholly or in part from such measures, including Company stock price and total stockholder return (“TSR”). A measure need not be presented in the Company’s financial statements or included in a filing with the SEC in order to be a Financial Reporting Measure.

3.11Incentive Compensation means any compensation that is granted, earned or vested based wholly or in part upon the attainment of a Financial Reporting Measure.

3.12Lookback Period means the three completed fiscal years immediately preceding the Accounting Restatement Date, as well as any transition period (resulting from a change in the Company’s fiscal year) within or immediately following those three completed fiscal years (except that a transition period of at least nine months shall count as a completed fiscal year). Notwithstanding the foregoing, the Lookback Period shall not include fiscal years completed prior to the Effective Date.

3.13Recoverable Incentive Compensation means Incentive Compensation received by a Covered Officer during the Lookback Period that exceeds the amount of Incentive Compensation that would have been received had such amount been determined based on the Accounting Restatement, computed without regard to any taxes paid (i.e., on a gross basis without regarding to tax withholdings and other deductions). For any compensation plans or programs that take into account Incentive Compensation, the amount of Recoverable Incentive Compensation for purposes of this Policy shall include, without limitation, the amount contributed to any notional account based on Recoverable Incentive Compensation and any earnings to date on that notional amount. For any Incentive Compensation that is based on stock price or TSR, where the Recoverable Incentive Compensation is not subject to mathematical recalculation directly from the information in an Accounting Restatement, the Administrator will determine the amount of Recoverable Incentive Compensation based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or TSR upon which the Incentive Compensation was received. The Company shall maintain documentation of the determination of that reasonable estimate and provide such documentation to the Exchange in accordance with the Listing Standards.

3.14SEC means the Securities and Exchange Commission.

2

Exhibit 97
4.RECOUPMENT OF CERTAIN INCENTIVE COMPENSATION AWARDED OR PAID TO EXECUTIVE OFFICERS

4.1Applicability of Policy. This Policy applies to Incentive Compensation received by a Covered Officer (i) after beginning services as an Executive Officer, (ii) who served as an Executive Officer at any time during the performance period for such Incentive Compensation, (iii) while the Company had a class of securities listed on a national securities exchange or a national securities association, and (iv) during the Lookback Period.

4.2Recoupment Generally. Pursuant to the provisions of this Policy, if there is an Accounting Restatement, the Company must reasonably promptly recoup the full amount of the Recoverable Incentive Compensation, unless the conditions of one or more subsections of Section 4(c) of this Policy are met and the Compensation Committee, or, if such committee does not consist solely of independent directors, a majority of the independent directors serving on the Board, has made a determination that recoupment would be impracticable. Recoupment is required regardless of whether the Covered Officer engaged in any misconduct and regardless of fault, and the Company’s obligation to recoup Recoverable Incentive Compensation is not dependent on whether or when any restated financial statements are filed.

4.3Impracticability of Recovery. Recoupment may be determined to be impracticable if, and only if:

4.3.1the direct expense paid to a third party to assist in enforcing this Policy would exceed the amount of the applicable Recoverable Incentive Compensation; provided that, before concluding that it would be impracticable to recover any amount of Recoverable Incentive Compensation based on expense of enforcement, the Company shall make a reasonable attempt to recover such Recoverable Incentive Compensation, document such reasonable attempt(s) to recover, and provide that documentation to the Exchange in accordance with the Listing Standards; or

4.3.2recoupment of the applicable Recoverable Incentive Compensation would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of Code Section 401(a)(13) or Code Section 411(a) and regulations thereunder.

4.4Sources of Recoupment. To the extent permitted by applicable law, the Administrator shall, in its sole discretion, determine the timing and method for recouping Recoverable Incentive Compensation hereunder, provided that such recoupment is undertaken reasonably promptly. The Administrator may, in its discretion, seek recoupment from a Covered Officer from any of the following sources or a combination thereof, whether the applicable compensation was approved, awarded, granted, payable or paid to the Covered Officer prior to, on or after the Effective Date: (i) direct repayment of Recoverable Incentive Compensation previously paid to the Covered Officer; (ii) cancelling prior cash or equity-based awards (whether vested or unvested and whether paid or unpaid); (iii) cancelling or offsetting against any planned future cash or equity-based awards; (iv) forfeiture of deferred compensation, subject to compliance with Code Section 409A; and (v) any other method authorized by applicable law or contract. Subject to compliance with any applicable law, the Administrator may effectuate recoupment under this Policy from any amount otherwise payable to the Covered Officer, including amounts payable to such individual under any otherwise applicable Company plan or program, e.g., base salary, bonuses or commissions and compensation previously deferred by the Covered Officer. The Administrator need not utilize the same method of recovery for all Covered Officers or with respect to all types of Recoverable Incentive Compensation.

4.5No Indemnification of Covered Officers. Notwithstanding any indemnification agreement, applicable insurance policy or any other agreement or provision of the Company’s certificate of
3

Exhibit 97
incorporation or bylaws to the contrary, no Covered Officer shall be entitled to indemnification or advancement of expenses in connection with any enforcement of this Policy by the Company, including paying or reimbursing such Covered Officer for insurance premiums to cover potential obligations to the Company under this Policy.

4.6Indemnification of Administrator. Any members of the Administrator, and any other members of the Board who assist in the administration of this Policy, shall not be personally liable for any action, determination or interpretation made with respect to this Policy and shall be indemnified by the Company to the fullest extent under applicable law and Company policy with respect to any such action, determination or interpretation. The foregoing sentence shall not limit any other rights to indemnification of the members of the Board under applicable law or Company policy.

4.7No “Good Reason” for Covered Officers. Any action by the Company to recoup or any recoupment of Recoverable Incentive Compensation under this Policy from a Covered Officer shall not be deemed (i) “good reason” for resignation or to serve as a basis for a claim of constructive termination under any benefits or compensation arrangement applicable to such Covered Officer, or (ii) to constitute a breach of a contract or other arrangement to which such Covered Officer is party.

5.ADMINISTRATION

Except as specifically set forth herein, this Policy shall be administered by the Administrator. The Administrator shall have full and final authority to make any and all determinations required under this Policy. Any determination by the Administrator with respect to this Policy shall be final, conclusive and binding on all interested parties and need not be uniform with respect to each individual covered by this Policy. In carrying out the administration of this Policy, the Administrator is authorized and directed to consult with the full Board or such other committees of the Board as may be necessary or appropriate as to matters within the scope of such other committee’s responsibility and authority. Subject to applicable law, the Administrator may authorize and empower any officer or employee of the Company to take any and all actions that the Administrator, in its sole discretion, deems necessary or appropriate to carry out the purpose and intent of this Policy (other than with respect to any recovery under this Policy involving such officer or employee).

6.SEVERABILITY

If any provision of this Policy or the application of any such provision to a Covered Officer shall be adjudicated to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Policy, and the invalid, illegal or unenforceable provisions shall be deemed amended to the minimum extent necessary to render any such provision or application enforceable.

4

Exhibit 97
7.NO IMPAIRMENT OF OTHER REMEDIES

Nothing contained in this Policy, and no recoupment or recovery as contemplated herein, shall limit any claims, damages or other legal remedies the Company or any of its affiliates may have against a Covered Officer arising out of or resulting from any actions or omissions by the Covered Officer. This Policy does not preclude the Company from taking any other action to enforce a Covered Officer’s obligations to the Company, including, without limitation, termination of employment and/or institution of civil proceedings. This Policy is in addition to the requirements of Section 304 of the Sarbanes-Oxley Act of 2002 (“SOX 304”) that are applicable to the Company’s Chief Executive Officer and Chief Financial Officer and to any other compensation recoupment policy and/or similar provisions in any employment, equity plan, equity award, or other individual agreement, to which the Company is a party or which the Company has adopted or may adopt and maintain from time to time; provided, however, that compensation recouped pursuant to this policy shall not be duplicative of compensation recouped pursuant to SOX 304 or any such compensation recoupment policy and/or similar provisions in any such employment, equity plan, equity award, or other individual agreement except as may be required by law.

8.AMENDMENT; TERMINATION

The Administrator may amend, terminate or replace this Policy or any portion of this Policy at any time and from time to time in its sole discretion. The Administrator shall amend this Policy as it deems necessary to comply with applicable law or any Listing Standard.

9.SUCCESSORS

This Policy shall be binding and enforceable against all Covered Officers and, to the extent required by Rule 10D-1 and/or the applicable Listing Standards, their beneficiaries, heirs, executors, administrators or other legal representatives.

10.REQUIRED FILINGS

The Company shall make any disclosures and filings with respect to this Policy that are required by law, including as required by the SEC.
5

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
3/31/25
6/30/24
Filed on:2/21/248-K
For Period end:12/31/23
10/2/23
8/19/204,  8-K
 List all Filings 


18 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/11/23  Tandem Diabetes Care Inc.         8-K:5      12/05/23   11:307K
 8/18/23  Tandem Diabetes Care Inc.         8-K:5,9     8/17/23   11:258K
 8/03/23  Tandem Diabetes Care Inc.         10-Q        6/30/23   75:7.1M
 5/03/23  Tandem Diabetes Care Inc.         10-Q        3/31/23   72:6.1M
 2/22/23  Tandem Diabetes Care Inc.         10-K       12/31/22   98:15M
 2/22/22  Tandem Diabetes Care Inc.         10-K       12/31/21   96:15M
11/03/21  Tandem Diabetes Care Inc.         10-Q        9/30/21   74:11M
 2/24/21  Tandem Diabetes Care Inc.         10-K       12/31/20   93:13M
 7/30/20  Tandem Diabetes Care Inc.         10-Q        6/30/20   67:7.4M
 5/15/20  Tandem Diabetes Care Inc.         8-K:1,2,3   5/12/20   14:1.4M
 4/30/20  Tandem Diabetes Care Inc.         10-Q        3/31/20   60:5.7M
11/09/18  Tandem Diabetes Care Inc.         10-Q/A      9/30/18    4:237K                                   ActiveDisclosure/FA
 4/26/18  Tandem Diabetes Care Inc.         DEF 14A     6/14/18    1:1.7M                                   ActiveDisclosure/FA
 1/16/18  Tandem Diabetes Care Inc.         S-1                    4:5.9M                                   Donnelley … Solutions/FA
 3/08/17  Tandem Diabetes Care Inc.         S-1                    4:3.1M                                   Donnelley … Solutions/FA
11/08/13  Tandem Diabetes Care Inc.         S-1/A                 13:5.8M                                   Donnelley … Solutions/FA
11/04/13  Tandem Diabetes Care Inc.         S-1/A      11/01/13   13:4.4M                                   Donnelley … Solutions/FA
10/07/13  Tandem Diabetes Care Inc.         S-1                   24:6.7M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001438133-24-000028   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 3, 4:30:09.2pm ET